A homophilic peptide from the T15 plasmacytoma inhibits growth of murine and human B cell tumors. This finding confirms the hypothesis that B cell malignancies are driven by a self-binding epitope in the B cell receoptor (BCR) proposed as the pathogenesis of chronic lymphocytic leukemia (CLL).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/mab.2013.0064 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!